MedVector aligns the incentives between treating physicians and investigator teams, enabling treating physicians to offer “clinical trials as a care option” without becoming an investigator or triggering a new site. We do this by using tools like telemedicine and other logistic tools without stepping into the DCT category. We would ask the clinical research site this: “Is there a local specialist who should be referring patients to your site but isn’t?" Typically, there are many doctors' names in front of their minds when asked this question. What we achieve in this approach is delivering an FDA-compliant site utility that allows community physicians to maintain control of the patient relationship while experienced PIs and sites maintain control of the protocol and GCP. https://www.medvector.com/how-it-works/
If you’ve ever lost sleep over delayed study enrollment, consider 1nHealth your new weighted blanket. 1nHealth fills studies through a simple philosophy: Don’t waste the power of…
Leveraging over 30 years of experience working with large biopharma, emerging biotech, CROs, and healthcare companies, the strategic advisors, executives, and subject matter…
Block Clinical is intently focused on streamlining the myriad of logistics involved in traditional, virtual, and hybrid clinical trials. From globally integrated patient…